ClorDiSys Partners with Nigerian Company for the Sale of Torch UV Disinfection System in West African States

Share Article

ClorDiSys Solution Inc., today announced it has entered into a five-year exclusive distribution agreement with Torlak Nigeria Limited, who will market and distribute the ClorDisys UV Torch Economic Communities of West African States (ECOWAS).

ClorDiSys’ premier Torch Ultraviolet Light Disinfection product is in the registration process for Africa’s NAFDAC (National Agency for Food and Drug Administration and Control) and SON (Standard Organization of Nigeria) certification. With the registrations in place in the first quarter of 2015, ClorDiSys will export its Torch to African government agencies and hospitals to join the effort to contain Ebola.

The Torch has been used at the University of Nebraska Medical Center’s Bio-containment Patient Care Unit to disinfect the rooms where Ebola patients have been treated. The Torch was also used at the Ohio Bridal Shop where Ebola-infected nurse visited to eradicate any trace of the virus.

“We are excited about this opportunity, and we see huge market potential as well as a chance to help in the fight against Ebola,” said Mark Czarneski, “Our Torch is cost-effective and is easy to operate with a 99.9% germ eradication rate within line of sight. Our products are already used by the World Health Organization and CDC in Africa, so we know that there is a tremendous need for them.”

About ClorDiSys Solutions, Inc.
ClorDiSys Solutions, Inc. was founded in 2001 as a spinoff from the Johnson & Johnson Co. The company has since been a leader in decontamination and sterilization of pharmaceutical, medical, veterinary, and food facilities. Currently ClorDysis is the select vendor for the U.S. military lab, federal health agencies and private hospitals.

ClorDiSys' cutting-edge Chlorine Dioxide and UV light disinfecting technology are being used by CDC and World Health Organization to stop the spread of the Ebola virus in West Africa as well as the prevention efforts in the United States.

About Torlak Nigeria Limited
The company is based in Abuja, Nigeria and was founded by Eze Emecheta in 1985. Torlak Nigeria Limited is a joint venture with Zevis Pharmaceuticals Ltd. The company imported vaccines and distributed biological substances produced by Torlak Institute before expanding its business to include medical equipment supply, Laboratory installation and commissioning, supply of medical devices and disposables. Torlak Nigeria Limited is among the select vendors of major health partners in Nigeria for DFID and EU. It is also a key procurement vendor in ECOWAS to provide anti-Ebola related protective gears and medical supplies.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Paul Lorcheim
ClorDiSys Solutions, Inc

Follow us on
Visit website